News

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

One of our most popular

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

For the quarter ended October 2025, Victoria's Secret (VSCO) reported revenue of $1.47 billion, up 9.2% over the same period last year. EPS came in at -$0.27, compared to -$0.50 in the year-ago

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

From a technical perspective, Synchronoss (SNCR) is looking like an interesting pick, as it just reached a key level of support. SNCR recently overtook the 200-day moving average, and this suggests

Fortinet (FTNT) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, FTNT broke through the 50-day moving average, which suggests a

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

From a technical perspective, Synchronoss (SNCR) is looking like an interesting pick, as it just reached a key level of support. SNCR recently overtook the 50-day moving average, and this suggests a

Peloton Interactive, Inc.’s PTON latest initiatives, Peloton IQ and the Cross-Training Series, signal a meaningful shift in how it intends to drive deeper, more consistent member engagement. Both

Shares of Bank of America BAC, the second-largest U.S. bank, are poised for another year of double-digit gains, building on its strong 30.5% rally in 2024.So far this year, BAC stock has risen

A consortium of Shell plc SHEL and Petróleo Brasileiro S.A. - Petrobras PBR recently announced the expansion of stakes in Brazil’s pre-salt region that continues to be a strategic growth engine for

Symbotic SYM and BitMine Immersion BMNR stand out within the Zacks Technology Services industry. Based in Wilmington, MA, Symbotic develops, markets and deploys advanced technology solutions that

CorMedix’s CRMD lead therapy, DefenCath (taurolidine + heparin), is currently the company’s majority revenue driver.

The FDA approved DefenCath in late 2023 as the first and only antimicrobial

Ryder System R is strengthening its Southeast growth strategy with the launch of its new full-service facility in McDonough, GA, a prime location near I-75 and major distribution hubs. By expanding

Chevron Corporation CVX and its partners in the Gorgon Joint Venture have officially sanctioned the $2 billion Gorgon Stage 3 development — an important step in extending the life and output of one